MYO5B and metastatic neoplasm: In contrast, metastatic tumors displayed a significantly stronger expression; 3/9 cases with intermediate expression and 6/9 displaying strong MYO5B expression compared to non-metastatic tumors (p = 0.007 by Mann-Whitney, 2-sided).